Kumar R, Goswami R, Agarwal S, Israni N, Singh S K, Rani R
Neuroimmunology Laboratory, National Institute of Immunology, Aruna Asafali Marg, New Delhi 110067, India.
Tissue Antigens. 2007 Jun;69(6):557-67. doi: 10.1111/j.1399-0039.2007.00817.x.
Type 1 diabetes (T1D) is a multifactorial autoimmune disorder where major histocompatibility complex (MHC) genes and the insulin-linked polymorphic region have been shown to play major roles. We report here an integrated effect of tumor necrosis factor (TNF) alpha with other cytokine genes. The TNF-alpha-308 GA and AA (high secretor) polymorphisms were significantly increased in the patients with T1D (n = 235) [P < 7 x 10(-6), odds ratio (OR) = 3.04, 95% confidence interval (CI) = 1.8-5.3] compared with the controls (n= 128). The variants of interferon-gamma (IFN-gamma) (A(+874)T), interleukin (IL)-6 (G(-174)C), IL-10 (A(-1082)G, T(-819)C, C(-592)A) and transforming growth factor (TGF) beta1 (T(cdn10)C, G(cdn25)C) did not show a significant difference between patients and controls. However, simultaneous presence of TNF-alpha-308 GA+AA along with both high and low secretor genotypes of IFN-gamma (P < 0.003) was significantly increased in patients. Simultaneous presence of TNF-alpha-308 GA + AA along with high secretor genotypes of IL-6 (P < 0.0001, OR = 2.61, 95% CI = 1.5-4.56), IL-10 (P < 0.0001, OR = 4.26, 95% CI = 1.9-10.1) and TGF-beta1 (P < 0.00004, OR = 2.8, 95% CI = 1.6-4.86) was also significantly increased in patients with T1D. Low secretor genotype of TNF-alpha-308 GG along with low secretor genotypes of IFN-gamma (P < 0.001, OR = 0.465, 95% CI = 0.28-0.77), high secretor genotypes of IL-6 (P < 0.000004, OR = 0.76, 95% CI = 0.227-0.621) and TGF-beta1 (P < 0.000006, OR = 0.336, 95% CI = 0.198-0.568) was protective. The TNF-alpha-308 G allele was in linkage disequilibrium (LD) with the human leukocyte antigen (HLA)-B0801-DRB10301 haplotype, while TNF-alpha-308 A allele was in LD with the HLA-B5001-DRB10301 and B5801-DRB10301 haplotypes, suggesting that the effect of TNF-alpha -308 A allele is not because of its being in LD with any HLA alleles, but because of its functional role and its integrated effect with other cytokines.
1型糖尿病(T1D)是一种多因素自身免疫性疾病,主要组织相容性复合体(MHC)基因和胰岛素连锁多态性区域已被证明起主要作用。我们在此报告肿瘤坏死因子(TNF)α与其他细胞因子基因的综合作用。与对照组(n = 128)相比,T1D患者(n = 235)中TNF-α -308 GA和AA(高分泌型)多态性显著增加[P < 7×10⁻⁶,优势比(OR)= 3.04,95%置信区间(CI)= 1.8 - 5.3]。干扰素-γ(IFN-γ)(A(+874)T)、白细胞介素(IL)-6(G(-174)C)、IL-10(A(-1082)G、T(-819)C、C(-592)A)和转化生长因子(TGF)β1(T(cdn10)C、G(cdn25)C)的变体在患者和对照组之间未显示出显著差异。然而,TNF-α -308 GA + AA与IFN-γ高分泌型和低分泌型基因型同时存在时(P < 0.003),患者中显著增加。TNF-α -308 GA + AA与IL-6高分泌型基因型(P < 0.0001,OR = 2.61,95% CI = 1.5 - 4.56)、IL-10高分泌型基因型(P < 0.0001,OR = 4.26,95% CI = 1.9 - 10.1)和TGF-β1高分泌型基因型(P < 0.00004,OR = 2.8,95% CI = 1.6 - 4.86)同时存在时,T1D患者中也显著增加。TNF-α -308 GG低分泌型基因型与IFN-γ低分泌型基因型(P < 0.001,OR = 0.465,95% CI = 0.28 - 0.77)、IL-6高分泌型基因型(P < 0.000004,OR = 0.76,95% CI = 0.227 - 0.621)和TGF-β1高分泌型基因型(P < 0.000006,OR = 0.336,95% CI = 0.198 - 0.568)同时存在时具有保护作用。TNF-α -308 G等位基因与人类白细胞抗原(HLA)-B0801 - DRB10301单倍型处于连锁不平衡(LD)状态,而TNF-α -308 A等位基因与HLA - B5001 - DRB10301和B5801 - DRB10301单倍型处于LD状态,这表明TNF-α -308 A等位基因的作用并非因其与任何HLA等位基因处于LD状态,而是因其功能作用及其与其他细胞因子的综合作用。